- Home
- CERO vs CTNT Comparison
CERO vs CTNT Comparison
Compare CERO & CTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- CTNT
- Stock Information
- Founded
- CERO 2017
- CTNT 2016
- Country
- CERO United States
- CTNT United States
- Employees
- CERO N/A
- CTNT N/A
- Industry
- CERO
- CTNT
- Sector
- CERO
- CTNT
- Exchange
- CERO Nasdaq
- CTNT Nasdaq
- Market Cap
- CERO 8.5M
- CTNT 9.3M
- IPO Year
- CERO N/A
- CTNT 2023
- Fundamental
- Price
- CERO $0.06
- CTNT $3.45
- Analyst Decision
- CERO
- CTNT Hold
- Analyst Count
- CERO 0
- CTNT 1
- Target Price
- CERO N/A
- CTNT N/A
- AVG Volume (30 Days)
- CERO 33.3M
- CTNT 6.1M
- Earning Date
- CERO 11-19-2024
- CTNT 11-13-2024
- Dividend Yield
- CERO N/A
- CTNT N/A
- EPS Growth
- CERO N/A
- CTNT N/A
- EPS
- CERO N/A
- CTNT N/A
- Revenue
- CERO N/A
- CTNT $7,703,113.00
- Revenue This Year
- CERO N/A
- CTNT N/A
- Revenue Next Year
- CERO N/A
- CTNT N/A
- P/E Ratio
- CERO N/A
- CTNT N/A
- Revenue Growth
- CERO N/A
- CTNT N/A
- 52 Week Low
- CERO $0.05
- CTNT $1.70
- 52 Week High
- CERO $12.80
- CTNT $236.16
- Technical
- Relative Strength Index (RSI)
- CERO 39.14
- CTNT 54.37
- Support Level
- CERO $0.05
- CTNT $2.83
- Resistance Level
- CERO $0.21
- CTNT $4.59
- Average True Range (ATR)
- CERO 0.02
- CTNT 0.88
- MACD
- CERO -0.01
- CTNT 0.05
- Stochastic Oscillator
- CERO 14.60
- CTNT 23.95
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a supplier of parallel-import vehicles sourced in the U.S. to be sold in the China market. The parallel-import vehicles refer to those purchased by dealers directly from overseas markets and imported for sale through channels other than brand manufacturers' official distribution systems. The company purchases automobiles, luxury brands such as Mercedes, BMW, Porsche, Lexus, and Bentley, from the U.S. market and resells them to customers, including both U.S. and PRC parallel-import car dealers. The company derives profits from the price difference between buying and selling prices for parallel-import vehicles.